Berrard S, Varoqui H, Cervini R, Israël M, Mallet J, Diebler M F
Laboratoire de Génétique Moléculaire de la Neurotransmission et des Processus Neurodégénératifs, CNRS, Gif sur Yvette, France.
J Neurochem. 1995 Aug;65(2):939-42. doi: 10.1046/j.1471-4159.1995.65020939.x.
The gene encoding the vesicular acetylcholine transporter (VAChT) has recently been localized within the first intron of the gene encoding choline acetyltransferase (ChAT) and is in the same transcriptional orientation. These two genes, whose products are required for the expression of the cholinergic phenotype, could therefore be coregulated. We thus tested the effects on VAChT gene expression of the cholinergic differentiation factor/leukemia inhibitory factor and retinoic acid, both of which induce ChAT activity and increase ChAT mRNA levels in cultured sympathetic neurons. These factors increased both the number of binding sites for vesamicol, a specific ligand of VAChT, and VAChT immunoreactivity. This increase in the number of VAChT molecules resulted from an increase in the amount of VAChT mRNA, as assessed by reverse transcription-PCR and which paralleled that of ChAT mRNAs. These data suggest a functional role for ChAT and VAChT gene organization and are consistent with the existence of a coregulatory mechanism for the embedded ChAT and VAChT genes.
编码囊泡乙酰胆碱转运体(VAChT)的基因最近被定位在编码胆碱乙酰转移酶(ChAT)的基因的第一个内含子内,并且转录方向相同。因此,这两个基因(其产物是胆碱能表型表达所必需的)可能受到共同调控。于是,我们测试了胆碱能分化因子/白血病抑制因子和视黄酸对VAChT基因表达的影响,这两种因子均可诱导培养的交感神经元中的ChAT活性并增加ChAT mRNA水平。这些因子增加了VAChT的特异性配体vesamicol的结合位点数量以及VAChT免疫反应性。通过逆转录-聚合酶链反应评估,VAChT分子数量的增加是由于VAChT mRNA量的增加,且这与ChAT mRNA的增加平行。这些数据表明ChAT和VAChT基因组织具有功能作用,并且与嵌入式ChAT和VAChT基因存在共同调控机制相一致。